We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.33%
2 Healthcare 8.9%
3 Financials 7.71%
4 Consumer Discretionary 6.92%
5 Industrials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADT icon
2451
ADT
ADT
$5.34B
$624K ﹤0.01%
+76,423
New +$744K
SLQT icon
2452
SelectQuote
SLQT
$126M
$624K ﹤0.01%
+30,827
New +$642K
EWX icon
2453
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$701M
$622K ﹤0.01%
14,008
-234
-2% -$10.4K
WDFC icon
2454
WD-40
WDFC
$3.09B
$621K ﹤0.01%
3,279
-252
-7% -$49.5K
MP icon
2455
MP Materials
MP
$9.91B
$619K ﹤0.01%
+45,569
New +$576K
SPYM
2456
State Street SPDR Portfolio S&P 500 ETF
SPYM
$170B
$618K ﹤0.01%
15,697
+2,386
+18% +$92.9K
AMCR icon
2457
Amcor
AMCR
$21.4B
$616K ﹤0.01%
11,146
+3,031
+37% +$165K
NG icon
2458
NovaGold Resources
NG
$3.45B
$616K ﹤0.01%
51,738
-56,663
-52% -$553K
CELL
2459
DELISTED
PhenomeX Inc. Common Stock
CELL
$616K ﹤0.01%
+8,070
New +$512K
VSAT icon
2460
Viasat
VSAT
$11.4B
$614K ﹤0.01%
17,867
+3,008
+20% +$114K
MSEX icon
2461
Middlesex Water
MSEX
$1.1B
$613K ﹤0.01%
9,861
+2,780
+39% +$180K
RIV
2462
RiverNorth Opportunities Fund
RIV
$319M
$612K ﹤0.01%
42,676
-2,852
-6% -$43.1K
FLGT icon
2463
Fulgent Genetics
FLGT
$515M
$611K ﹤0.01%
15,250
-12,170
-44% -$381K
KURA icon
2464
Kura Oncology
KURA
$896M
$611K ﹤0.01%
19,938
+1,028
+5% +$22.7K
SHLX
2465
DELISTED
Shell Midstream Partners, L.P.
SHLX
$610K ﹤0.01%
64,524
+10,904
+20% +$119K
SURF
2466
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$607K ﹤0.01%
+88,039
New +$534K
ESLT icon
2467
Elbit Systems
ESLT
$36.5B
$603K ﹤0.01%
4,954
-189
-4% -$24.9K
ETFC
2468
DELISTED
E*Trade Financial Corporation
ETFC
$603K ﹤0.01%
12,038
-2,063
-15% -$108K
CLR
2469
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$601K ﹤0.01%
48,899
-392
-0.8% -$6.37K
ENPH icon
2470
Enphase Energy
ENPH
$5.39B
$600K ﹤0.01%
7,260
-2,045
-22% -$137K
BWX icon
2471
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$598K ﹤0.01%
20,140
+353
+2% +$10.5K
OTTR icon
2472
Otter Tail
OTTR
$3.87B
$598K ﹤0.01%
16,546
+8,158
+97% +$314K
TRNS icon
2473
Transcat
TRNS
$888M
$595K ﹤0.01%
20,314
-27,985
-58% -$797K
GEF icon
2474
Greif
GEF
$5.03B
$594K ﹤0.01%
16,399
-738
-4% -$27.2K
AADR icon
2475
AdvisorShares Dorsey Wright ADR ETF
AADR
$39.1M
$592K ﹤0.01%
10,703
+1,210
+13% +$68.2K

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.